Regulatory Upgrades and Market Adjustments Define Brazil’s Carbon Market and RenovaBio in 2025

The Brazilian carbon market remains in flux amid pivotal regulatory and institutional advances. The coexistence of the sector-specific RenovaBio program and the broader multilateral SBCE demands integration, aiming to prevent overlaps or gaps in emissions accounting and credit issuance. RenovaBio, established under Law 13.576/2017, continues to drive decarbonization in the fuels industry through mandatory distributor targets and voluntary producer certification, anchored in the RenovaCalc lifecycle methodology. Credits issued (CBIOs) represent avoided CO2e emissions and circulate on the B3 exchange. In contrast, the SBCE, instituted by Law 15.042/2024, operates a cap-and-trade framework targeting large emitters, issuing tradable emission permits (CBEs) and certified emission reduction/removal certificates (CRVEs) to facilitate compliance. The legal challenge lies in articulating dialogue and potential convergence between these two regulatory mechanisms while safeguarding environmental integrity and market certainty.

In 2025, RenovaBio faces transitional challenges due to delayed enforcement of stricter sanctions under the new CBIO law, now effective only from 2026, following an AGU legal opinion. This postponement allows distributors a regulatory adjustment period as the new rules phase in. Meanwhile, contract-based discounts for long-term biocombustible purchase agreements have lowered effective distributor targets, cumulatively reducing total CBIO compliance demands from the projected 40.4 million to 38.9 million for 2025. Incorporating outstanding noncompliance obligations, the definitive target reaches 49.4 million CBIOs, consequently lifting credit supply estimates to around 17.9 million by year-end. These dynamics contributed to CBIO price declines, with March 2025 prices falling to R$68.90 and trading volumes down 15% monthly but exceeding prior-year activity.

Market rebalancing prospects are underscored by recent retirements of CBIOs from previously noncompliant major distributors, suggesting improved adherence trajectories. At the same time, the regulatory framework is strengthened through ANP’s release of updated technical reports governing certification, monitoring, and credit issuance procedures. These revisions enhance audit stringency, data transparency, and supply chain traceability to bolster credibility and investor confidence in carbon assets. Finally, the newly established SBCE governance structures, including an Interministerial Committee and dedicated regulatory bodies, set the stage for coherent policy execution, emission cap setting, and price stabilization mechanisms.

Overall, Brazil’s carbon market evolution in 2025 reflects significant systemic fine-tuning driven by legal, operational, and market factors. The interplay of RenovaBio’s sectoral incentives with SBCE’s economy-wide cap-and-trade system remains central to achieving credible carbon pricing and expanded decarbonization efforts as the country advances toward its climate goals.